Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Justin L Garner

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
Respiration; International Review of Thoracic Diseases|January 23, 2020
5-Year Survival after Endobronchial Coil Implantation: Secondary Analysis of the First Randomised Controlled Trial, RESETJustin L Garner, Samuel V Kemp, Karthi Srikanthan, et al.
Access Microbiology|June 24, 2026
Investigating the lasting effects of SARS-CoV-2 infection and the lung microbiome: no persistent microbial alterations in recovered COVID-19 patients with persistent radiological or respiratory abnormalitiesNancy M Y Teng, Bavithra Vijayakumar, David J F Smith, et al.
Respiratory Research|February 20, 2021
Safety of denervation following targeted lung denervation therapy for COPD: AIRFLOW-1 3-year outcomesChristophe Pison, Pallav L Shah, Dirk-Jan Slebos, et al.
Respiratory Research|March 16, 2021
Correction to: Safety of denervation following targeted lung denervation therapy for COPD: AIRFLOW-1 3-year outcomesChristophe Pison, Pallav L Shah, Dirk-Jan Slebos, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|November 4, 2020
Intra-alveolar neutrophil-derived microvesicles are associated with disease severity in COPDSanooj Soni, Justin L Garner, Kieran P O'Dea, et al.
American Journal of Respiratory and Critical Care Medicine|May 19, 2025
Airway Scaffolds for Emphysema-related Hyperinflation - Six-Month Results from the BREATHE TrialAnand Tana, Arschang Valipour, Alvin Ing, et al.
Immunity|February 13, 2022
Immuno-proteomic profiling reveals aberrant immune cell regulation in the airways of individuals with ongoing post-COVID-19 respiratory diseaseBavithra Vijayakumar, Karim Boustani, Patricia P Ogger, et al.
Annals of the American Thoracic Society|April 1, 2020
Effect of Zephyr Endobronchial Valves on Dyspnea, Activity Levels, and Quality of Life at One Year. Results from a Randomized Clinical TrialMark T Dransfield, Justin L Garner, Surya P Bhatt, et al.
Thorax|June 5, 2026
Establishing the top 10 research priorities for lung volume reduction treatment for people with COPDSara C Buttery, Richard Barraclough, Timothy J P Batchelor, et al.
BMJ Open|January 4, 2024
Determining the impact of an artificial intelligence tool on the management of pulmonary nodules detected incidentally on CT (DOLCE) study protocol: a prospective, non-interventional multicentre UK studyEmma O'Dowd, Marko Berovic, Matthew Callister, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Respiration; International Review of Thoracic Diseases|January 23, 2020
5-Year Survival after Endobronchial Coil Implantation: Secondary Analysis of the First Randomised Controlled Trial, RESETJustin L Garner, Samuel V Kemp, Karthi Srikanthan, et al.
Access Microbiology|June 24, 2026
Investigating the lasting effects of SARS-CoV-2 infection and the lung microbiome: no persistent microbial alterations in recovered COVID-19 patients with persistent radiological or respiratory abnormalitiesNancy M Y Teng, Bavithra Vijayakumar, David J F Smith, et al.
Respiratory Research|February 20, 2021
Safety of denervation following targeted lung denervation therapy for COPD: AIRFLOW-1 3-year outcomesChristophe Pison, Pallav L Shah, Dirk-Jan Slebos, et al.
Respiratory Research|March 16, 2021
Correction to: Safety of denervation following targeted lung denervation therapy for COPD: AIRFLOW-1 3-year outcomesChristophe Pison, Pallav L Shah, Dirk-Jan Slebos, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|November 4, 2020
Intra-alveolar neutrophil-derived microvesicles are associated with disease severity in COPDSanooj Soni, Justin L Garner, Kieran P O'Dea, et al.
American Journal of Respiratory and Critical Care Medicine|May 19, 2025
Airway Scaffolds for Emphysema-related Hyperinflation - Six-Month Results from the BREATHE TrialAnand Tana, Arschang Valipour, Alvin Ing, et al.
Immunity|February 13, 2022
Immuno-proteomic profiling reveals aberrant immune cell regulation in the airways of individuals with ongoing post-COVID-19 respiratory diseaseBavithra Vijayakumar, Karim Boustani, Patricia P Ogger, et al.
Annals of the American Thoracic Society|April 1, 2020
Effect of Zephyr Endobronchial Valves on Dyspnea, Activity Levels, and Quality of Life at One Year. Results from a Randomized Clinical TrialMark T Dransfield, Justin L Garner, Surya P Bhatt, et al.
Thorax|June 5, 2026
Establishing the top 10 research priorities for lung volume reduction treatment for people with COPDSara C Buttery, Richard Barraclough, Timothy J P Batchelor, et al.
BMJ Open|January 4, 2024
Determining the impact of an artificial intelligence tool on the management of pulmonary nodules detected incidentally on CT (DOLCE) study protocol: a prospective, non-interventional multicentre UK studyEmma O'Dowd, Marko Berovic, Matthew Callister, et al.
Pageof 4